Metagenomi, Inc. Common Stock
MGX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $52,295 | $44,756 | $17,200 | $243 |
| % Growth | 16.8% | 160.2% | 6,978.2% | – |
| Cost of Goods Sold | $0 | $94,403 | $1,733 | $387 |
| Gross Profit | $52,295 | -$49,647 | $15,467 | -$144 |
| % Margin | 100% | -110.9% | 89.9% | -59.3% |
| R&D Expenses | $109,179 | $94,403 | $43,139 | $14,478 |
| G&A Expenses | $32,017 | $28,845 | $18,701 | $9,712 |
| SG&A Expenses | $32,017 | $28,845 | $18,701 | $9,712 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$94,403 | -$1,733 | -$387 |
| Operating Expenses | $141,196 | $28,845 | $60,107 | $23,803 |
| Operating Income | -$88,901 | -$78,492 | -$44,640 | -$23,947 |
| % Margin | -170% | -175.4% | -259.5% | -9,854.7% |
| Other Income/Exp. Net | $5,330 | $18,264 | $3,616 | $2,505 |
| Pre-Tax Income | -$83,571 | -$60,228 | -$41,024 | -$21,442 |
| Tax Expense | -$5,513 | $8,027 | $2,569 | $0 |
| Net Income | -$78,058 | -$68,255 | -$43,593 | -$21,442 |
| % Margin | -149.3% | -152.5% | -253.4% | -8,823.9% |
| EPS | -2.09 | -1.82 | -1.16 | -3.62 |
| % Growth | -14.8% | -56.9% | 68% | – |
| EPS Diluted | -2.09 | -1.82 | -1.16 | -3.62 |
| Weighted Avg Shares Out | 37,418 | 37,472 | 37,472 | 5,930 |
| Weighted Avg Shares Out Dil | 37,418 | 37,472 | 37,472 | 5,930 |
| Supplemental Information | – | – | – | – |
| Interest Income | $14,722 | $15,468 | $3,419 | $43 |
| Interest Expense | $0 | $0 | $98 | $302 |
| Depreciation & Amortization | $5,407 | $4,207 | $1,733 | $387 |
| EBITDA | -$83,494 | -$74,285 | -$39,193 | -$20,753 |
| % Margin | -159.7% | -166% | -227.9% | -8,540.3% |